Waters Q4 sales rise 7% to $932 million; 2026 non-GAAP EPS guided at $14.30-$14.50
Waters reported fourth-quarter 2025 sales of $932 million, up 7% as reported, and non-GAAP EPS of $4.53, up 10%. GAAP diluted EPS fell to $3.77 from $3.88, and the company said it would close its acquisition of Becton, Dickinson's Biosciences and Diagnostic Solutions business on the release date and guided 2026 reported revenue to $6.405 billion to $6.455 billion.
Key points
- Q4 2025 sales $932 million, up 7% as reported and 6% in constant currency
- Q4 GAAP diluted EPS $3.77 vs $3.88 a year earlier; non-GAAP EPS $4.53 vs $4.10
- Full-year 2025 sales $3,165 million, up 7%; GAAP EPS $10.76, non-GAAP EPS $13.13
- 2026 guidance: non-GAAP EPS $14.30 to $14.50 and reported revenue $6.405 billion to $6.455 billion, including about $3.000 billion from the acquired business
The filing
Written by AI (Anthropic Claude, claude-haiku-5-5) on Nov 8, 2026, 1:30 AM ET, from the text of the filing and its press-release exhibits only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on February 09, 2026.
Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.